Did you know you can stay up-to-date with all of our posts via our daily e-mail newsletter? Sign up today!
online pharmacy purchase symbicort-inhaler no prescription with best prices today in the USA
online pharmacy purchase lariam online no prescription
online pharmacy norvasc for sale no prescription
Quote of the Day
"Don’t mine for gold where everyone else is mining for gold—sell shovels instead."
(Ramp Captal)
Markets
- Low vol and momentum have been the two best performing factors in 2019. (capitalspectator.com)
- "Everybody indexing" is a theoretical concern. (morningstar.com)
Companies
- Apple ($AAPL) is all about keeping you in the ecosystem. (axios.com)
- The downside of Apple ($AAPL) App Store success: Apple may copy you. (washingtonpost.com)
Finance
- In practice, IPO investors focus on revenue growth, not profits. (barrons.com)
- Bill Ackman-managed Pershing Square Holdings still trades a huge discount to NAV. (bloomberg.com)
Funds
- Why competing against Vanguard is so difficult. (morningstar.com)
- The ETF tempts investors to trade something they never should. (epsilontheory.com)
- Don't discount the transformative effect mutual funds and ETFs have had. (vanguardblog.com)
Housing
Economy
- The August NFP report showed slowing jobs growth. (calculatedriskblog.com)
- The risk of a 2020 recession is rising. (fat-pitch.blogspot.com)
Earlier on Abnormal Returns
- Podcast links: hardcore listeners. (abnormalreturns.com)
- What you missed in our Thursday linkfest. (abnormalreturns.com)
- Startup links: gradual growth. (abnormalreturns.com)
- In the future every asset will be tradeable, even sports teams. (abnormalreturns.com)
- Monthly ESG links: understanding risks. (abnormalreturns.com)
Mixed media
- The best way to consume information is through books that have stood the test of time. (ofdollarsanddata.com)
- Design matters: the case of food expiration dates. (fastcompany.com)
- Admitting you are wrong is difficult, but necessary. (pointsandfigures.com)
- The most effective misinformation has a seed of truth to it. (scientificamerican.com)
